Clinical Trial Detail

NCT ID NCT01222143
Title Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University Health Network, Toronto
Indications

acute myeloid leukemia

Therapies

Cytarabine + Etoposide + Mitoxantrone

Nilotinib

Age Groups: adult

Additional content available in CKB BOOST